Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?

To: Fang Li who wrote (15622)	4/8/1998 12:54:00 AM
From: THOMAS GOODRICH	Read Replies (1) \| Respond to of 29386

Why do you get the impression Ancor is a "poison pill" company, i.e. against M&A? I believe the management team will consider a buyout plan when the time is right. I just don't think Ancor's ripe for picking just yet, nor, would it probably be in the best interest of the stockholders (or stuckholders, depending on how you look at it!)<g> to sell-out at the current low price point. There are indeed lots of shrimp out there and at least a few big ones should end up on Ancor's plate. And yes, no doubt Ancor will have to share a few with some even bigger fishes. BTW, I really don't think Ancor's strategy is to just buy some time and wait until the market is developed by others. Quite the contrary.